bendamustine sandoz 2,5 mg/ml pulveris infūziju šķīduma koncentrāta pagatavošanai
sandoz d.d., slovenia - bendamustīna hidrohlorīds - pulveris infūziju šķīduma koncentrāta pagatavošanai - 2,5 mg/ml
movalis 7,5 mg tabletes
boehringer ingelheim international gmbh, germany - meloksikāms - tablete - 7,5 mg
movalis 15 mg tabletes
boehringer ingelheim international gmbh, germany - meloksikāms - tablete - 15 mg
irinotecan ebewe 20 mg/ml koncentrāts infūziju šķīduma pagatavošanai
sandoz d.d., slovenia - irinotekāna hidrohlorīda trihidrāts - koncentrāts infūziju šķīduma pagatavošanai - 20 mg/ml
methotrexat-ebewe 5 mg tabletes
ebewe pharma ges.m.b.h nfg.kg, austria - metotreksāts - tablete - 5 mg
methotrexat-ebewe 5 mg tabletes
ebewe pharma ges.m.b.h nfg.kg, austria - metotreksāts - tablete - 5 mg
methotrexat-ebewe 5 mg tabletes
ebewe pharma ges.m.b.h nfg.kg, austria - metotreksāts - tablete - 5 mg
methotrexat-ebewe 5 mg tabletes
ebewe pharma ges.m.b.h nfg.kg, austria - metotreksāts - tablete - 5 mg
dynepo
shire pharmaceutical contracts limited - epoetīna delta - kidney failure, chronic; anemia - antianēmiski līdzekļi - dynepo ir indicēts simptomātiskas anēmijas, kas saistīta ar hronisku nieru mazspēju (crf), ārstēšanai pieaugušiem pacientiem. to var lietot pacientiem, kas saņem dialīzi, un pacientiem, kam nav dialīzes.
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - imūbnglobulīns, normālais, cilvēka - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - un imūnglobulīni, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.